Tectonic Therapeutic (NASDAQ:TECX) Announces Earnings Results, Beats Estimates By $0.17 EPSMarket Beat·Aug 7 at 06:11 PMTECX+15.56%
Piper Sandler Sticks to Its Buy Rating for Tectonic Therapeutic (TECX)Tip Ranks·Aug 7 at 10:28 AMTECX+15.56%
The Misfits and the Money Machines: Inside the Market’s Weirdest CornerGlobal Report·Aug 4 at 04:17 AMTBCH-0.08%LYB-1.84%
Orbimed Advisors LLC Has $7 Million Stock Position in Tectonic Therapeutic, Inc. $TECXMarket Beat·Jul 27 at 05:24 AMTECX+15.56%
5 Biotech Stocks That Delivered 100% To 300% Gains: Did Your Winning Trades Offset Portfolio Losses?rttnews·Jul 6 at 04:55 AMURGN+4.01%CLYM+3.90%
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watchrttnews·Jul 3 at 12:19 AMCMMB+1.05%SLS+6.52%
Tectonic Therapeutic CSO Peter McNamara disposes of USD 6,020 in common sharesPUBT·Jul 1 at 04:20 PMTECX+15.56%
LifeSci Capital Remains a Buy on Tectonic Therapeutic (TECX)Tip Ranks·May 9 at 09:09 PMTECX+15.56%IBB+0.49%
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Receives Consensus Rating of "Moderate Buy" from BrokeragesMarket Beat·Apr 29 at 05:53 AMTECX+15.56%IBB+0.49%
